BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
7 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
    Im CM; Cho IJ; Yu HJ; Han B; Oh HH; Seo YJ; Kim KH; Myung DS; Cho SB; Lee WS; Nam TK; Joo YE
    Anticancer Res; 2022 Dec; 42(12):5951-5959. PubMed ID: 36456158
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in cervical cancer.
    Lang X; Huang C; Cui H
    J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy.
    Bohr Mordhorst L; Ahlin C; Sorbe B
    Oncotarget; 2016 Sep; 7(39):63042-63053. PubMed ID: 27577083
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system.
    Park S; Jeong JS; Ryu HR; Lee CR; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    J Korean Med Sci; 2013 May; 28(5):693-9. PubMed ID: 23678260
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
    Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
    Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
    Widel M; Jedruś S; Owczarek S; Konopacka M; Lubecka B; Kołosza Z
    Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.